2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z

Obesity Is Associated with Increased Risk of ESRD Among Living Kidney Donors.

J. Locke,¹ C. Lewis,¹ R. Reed,¹ V. Kumar,¹ D. Sawinski,² A. Massie,³ P. MacLennan,¹ R. Mannon,¹ R. Gaston,¹ D. Segev.³
Obliterative Bronchiolitis Following Lung Transplantation Is Preceded by Depletion of Airway Submucosal Glands and Basal Stem Cells.

A. Swatek, A. Crooke, P. Anderson, T. Lynch, M. Ivanovic, J. Klesney-Tait, M. Eberlein, T. Pena, J. Engelhardt, K. Parekh.
Occult Multifocal Hepatocellular Carcinoma in Surgical Patients.

D. Aufhauser Jr,¹ E. Sadot,² D. Murken,¹ K. Eddinger,¹ D. Goldberg,³ E. Furth,⁴ P. Abt,¹ R. DeMatteo,² M. Levine.¹
Offering HCV-Positive Kidneys to HCV-Negative Patients on the Kidney Transplant Waitlist Is Lifesaving: Results of a Markov Model.

D. Goldberg, P. Reese, V. Potluri, F. Scott.
Older Patients Reliably Participate in Automated Living Donor Follow Up Rather Than Avoiding This New Technology.

H. Braun, M. Parente, R. Hirose, G. Roll.
One Year Post VZV Booster: Still Equal Response in Renal Transplant Recipients Compared to Healthy Persons.

M. Kho,¹ W. Weimar,¹ M. Boer-Verschragen,¹ A. van der Eijk,² N. van Besouw.¹
One-Year Graft Loss Risk in Kidney Transplants – A Big Data Approach.

T. Srinivas, D. Taber, J. Zhang, Z. Su, J. Marsden, A. Tripathi, W. Moran, P. Mauldin.
Only 13% of Liver Transplant (LT) Recipients with Moderate to Severe Kidney Disease (KD) Tolerate Conversion to Everolimus and Reduced Tacrolimus (EVR/rTac).

S.-H. Pan, I. Kim, A. Klein, A. Annamalai, T. Todo, N. Nissen.
Opioid-Sparing Pain Management Improves Outcomes and Safety in Living Liver Donors.

D. Ladner,¹ E. Pomfret,² M. Simpson,² J. Guarrera,³ R. Fisher,⁴ A. Skaro,¹ T. Baker,¹ T. Curtis,¹ A. Daud,¹ B. Platt,¹ R. Kang,¹ N. Salehitezangi,¹ J. Holl,¹ M. Abecassis,¹ D. Woods.¹
Optimal Donor/Recipient Pairing for High KDPI Grafts Can Yield Similar Survival to Medium KDPI Grafts.

M. Selim, E. Saad, M. Zimmerman, C. Johnson.
Optimal Integration of Kidney Exchange Programs with Antibody Reduction Therapy to Increase Successful Transplant in Difficult to Match Recipients.

K. Melancon,¹ N. Koizumi,² M. Gentili,³ C. Callender.⁴
Optimal Measures for Timely Transplantation: Reviewing Correlation Between Early Transplantation Wait-Listing and Transplantation Outcomes.

M. Brown, K. Polkinghorne, J. Kanellis.
Optimized Flow Cytometry Crossmatch with Increased Sensitivity and Specificity.

K. Barrios,¹ J. Lunz,¹ B. Labuda,¹ D. Magas,¹ D. Freedom,¹ K. Szewczyk,¹ M. Jendrisak,¹ A. Jaramillo.^1,2
Optimizing CPRAs for Sensitized Kidney Waitlist Candidates: The Devil Is in the KAS Details.

J. Houp,¹ R. Vega,¹ B. Lonze,² N. Desai,² R. Montgomery,² A. Jackson.¹
Optimizing the Immunogenicity and Immunomodulatory Properties of MSC for Cellular Therapy.

S. de Witte,¹ M. Franquesa,¹ T. Strini,¹ S. Korevaar,¹ F. Luk,¹ S. Elliman,² P. Newsome,³ M. Gargesha,⁴ D. Roy,⁴ A. Merino,¹ C. Baan,¹ M. Hoogduijn.¹
Original KDRI Predicts Kidney Graft Failure in a Brazilian Cohort.

J. Reusing Jr.,¹ C. Nihei,¹ A. Lino de Souza,² E. David-Neto,¹ C. Ventura.³
Outcome After Kidney Transplant (KTx) in Patients with Chronic Hypotension on Haemodialysis (HD).

O. Manolitsi, N. Kessaris, J. Olsburgh, I. Loukopoulos.
Outcome of Partial Reconstruction of Multiple Hepatic Arteries in Pediatric Living Donor Liver Transplantation Using Left Lateral Section Grafts.

K. Lee, K. Kim, S. Kim, J. Lee, J. Lee, N. Lee, C. Cho, S. Lee, G. Choi, C. Kwon, J.-W. Joh, S.-K. Lee.
Outcome of the Various Pathology Grades of Antibody-Mediated Rejection After Heart Transplantation.

J. Patel, M. Kittleson, D. Chang, T. Aintablian, L. Czer, A. Trento, J. Kobashigawa.
Outcomes Associated with Carbapenem-Resistant Enterobacteriaceae Infection After Solid Organ Transplantation in a Multicenter Study.

S. Huprikar,¹ L. Casner,¹ L. Camera Pierrotti,² A. Nellore,³ R. Madan,⁴ J. Garcia-Diaz,⁵ S. Jacobs,⁶ D. Lee,⁷ W. Trindade Clemente,⁸ G. Alangaden,⁹ R. La Hoz,¹⁰ N. Theodoropoulos,¹¹ M. Miceli,¹² G. Santoro-Lopes,¹³ D. Banach,¹⁴ D. Simon,¹⁵ G. Patel.¹
Outcomes Following Appendectomy in Kidney Transplant Recipients.

S. DiBrito, I. Olorundare, C. Landazabal, D. Segev, N. Dagher.
Outcomes Following Appendectomy in Liver Transplant Recipients.

N. Dagher, S. DiBrito, I. Olorundare, C. Landazabal, D. Segev.
Outcomes Following Inguinal Hernia Repair in Kidney Transplant Recipients.

S. DiBrito, I. Olorundare, C. Landazabal, D. Segev, N. Dagher.
Outcomes Following Inguinal Hernia Repair in Liver Transplant Recipients.

N. Dagher, S. DiBrito, I. Olorundare, C. Landazabal, D. Segev.
Outcomes Following Inguinal Hernia Repair in Patients with End Stage Liver Disease.

N. Dagher, S. DiBrito, I. Olorundare, C. Landazabal, D. Segev.
Outcomes for Kidney Allograft Recipients with Language Barriers Post-Transplantation – A Comparative Analysis.

S. Tahir,¹ F. Jackson-Spence,¹ H. Gillott,¹ F. Everson,² J. Nath,² A. Sharif.²
Outcomes for Liver Transplantation Using Organs from Donation After Cardiac Death Donors: A Single Center Experience.

J. Vanatta, X. Zhao, V. Puri, R. Helmick, S. Nair, S. Satapathy, J. Eason.
Outcomes from De Novo Tacrolimus Weight-Based Dosing Compared to Conservative Dosing in Kidney Transplant Recipients.

B. Summers,² K. Szempruch,¹ M. Harris,² A. Quidley,¹ C. Haisch,¹ A. Maldonado.¹
Outcomes in Black vs Non-Black Patients Administered Belatacept (Bela) or Cyclosporine (CsA) in BENEFIT-EXT.

S. Florman,¹ A. Durrbach,² V. Duro Garcia,³ K. Calderon,⁴ U. Meier-Kriesche,⁴ M. Polinsky,⁴ H. Zhao,⁴ J. Medina Pestana.⁵
Outcomes in Black vs Non-Black Patients Administered Belatacept (Bela) or Cyclosporine (CsA) in BENEFIT.

F. Vincenti,¹ J. Medina Pestana,² M. Abouljoud,³ B. Bresnahan,⁴ V. Duro Garcia,⁵ L. Mulloy,⁶ K. Rice,⁷ L. Rostaing,⁸ C. Zayas,⁹ K. Calderon,¹⁰ U. Meier-Kriesche,¹⁰ M. Polinsky,¹⁰ H. Zhao,¹⁰ C. Larsen.¹¹
Outcomes in Elderly Renal Transplant Recipients Using Thymoglobulin or Interleukin-2 Receptor Antagonist Induction.

N. Jasiak,¹ J. Thielke,¹ J. Chen,² N. Hilal,¹ S. Salah,¹ D. Wu,¹ E. Benedetti,² P. West-Thielke.^1,2
Outcomes in Lung Transplant Patients Requiring Extracorporeal Membrane Oxygenation (ECMO) in the Perioperative Period.

A. Habertheuer, M. Williams, S. Miller, E. Cantu, C. Bermudez, P. Vallabhajosyula.
Outcomes in Obese Renal Transplant Recipients Using High versus Low-Dose Thymoglobulin.

N. Jasiak,¹ C. Stromayer,¹ J. Thielke,¹ J. Chen,² J. Chen,¹ B. Talon,¹ R. Rubin-Tobar,¹ E. Benedetti,² P. West-Thielke.^1,2
Outcomes of Anticoagulation Use for Portal Vein Thrombosis in University of Wisconsin Liver Transplant Patients.

M. Falls,¹ A. Said,² L. Fernandez,² D. Foley,² K. Frith,¹ D. Hager,² H. Hoy,¹ G. Leverson,² J. Mezrich,² T. Prickette,² M. Wakefield,² A. D'Alessandro.²
Outcomes of Aorto-Hepatic Conduit During Liver Transplantation – A 31-Year, Single Center Experience.

A. Gupta, T. Anthony, R. Goldstein, G. McKenna, N. Onaca, R. Ruiz, G. Testa, G. Klintmalm, P. Kim.
Outcomes of Arterial and Venous Conduits for Vessel Reconstruction in Liver Transplantation.

J. Tan,¹ G. Oniscu.²
Outcomes of Deceased Donor Kidney Transplantation from Diabetic Donors: Does Presence of Recipient Diabetes Matter?

J. Rogers,¹ A. Farney,¹ G. Orlando,¹ A. Reeves-Daniel,² A. Palanisamy,² H. El-Hennawy,¹ M. Khan,¹ M. Gautreaux,¹ S. Iskandar,³ W. Doares,⁴ S. Kaczmorski,⁴ R. Stratta.¹
Outcomes of Depleting Antibody Induction in Kidney Transplantation: A Paired Kidney Analysis.

M. Sampaio, B. Chopra, K. Sureshkumar.
Outcomes of Donor Nephrectomy (DN) in the Obese.

O. Serrano,¹ A. Bangdiwala,² D. Vock,³ E. Minja,¹ W. Payne,¹ T. Dunn,¹ S. Chinnakotla,¹ E. Finger,¹ T. Pruett,¹ A. Matas,¹ R. Kandaswamy.¹
Outcomes of Donor Nephrectomy in the Elderly.

O. Serrano,¹ A. Bangdiwala,² K. Yadav,¹ A. Adamusiak,¹ D. Vock,³ W. Payne,¹ T. Dunn,¹ S. Chinnakotla,¹ E. Finger,¹ T. Pruett,¹ A. Matas,¹ R. Kandaswamy.¹
Outcomes of Ductoplasty in Right Lobe Living Donor Grafts with More Than One Bile Duct.

S. Kapoor, V. Varma, B. Nath, V. Kumaran.
Outcomes of EVAR in Kidney Transplant Recipients: Results form a National Quality Initiative.

I. Bostock,¹ D. Zarkowsky,¹ D. Stone,¹ M. Eslami,² M. Malas,³ P. Goodney.¹
Outcomes of Hispanic Kidney Transplant Recipients Under a Cyclosporine versus Tacrolimus Based Immunosuppression Protocol.

P. West-Thielke, A. Lasky, J. Thielke, M. Campara, E. Benedetti.
Outcomes of Isolated Pediatric Small Intestine Transplants Using Vascular Homografts.

Y. Kwon, N. Llore, R. Girlanda, K. Etesami, C. Desai, C. Matsumoto, T. Fishbein.
Outcomes of Kidney Transplantation in Obese Recipients – Single Center Experience.

A. El-Hinnawi, A. Rajab, G. Bumgardner, L. Haj Naser, R. Plews, I. James, M. Henry, R. Pelletier.
Outcomes of Liver Grafts from Donors with Very High Transaminases.

P. Martins, A. Rawson, P. Mahboub, B. Movahedi, N. Dolgin, I. Bruggenwirth, A. Bozorgzadeh.
Outcomes of Living and Deceased Donor Liver Transplant Recipients According to the MELD Score.

J. Lee, J. Lee, S. Song, J. Lee, S.-K. Kwon, D. Joo, M. Ju, G. Choi, J. Choi, S. Kim, M. Kim.
Outcomes of Pediatric en Bloc Kidney (PeB) Grafts After Loss of a Single Kidney.

C. Santhanakrishnan, R. Perez, J. McVicar, J. Sageshima, C. Troppmannn.
Outcomes of Ribavirin Free Treatment of Recurrent Genotype 1 , Hepatitis C Infection Post Liver Transplant.

D. Jones,¹ S. Baggett,¹ M. Shoreibah,² O. Massoud.²
Outcomes of Second Kidney Transplantation Compared Primary Transplantation According to Donor Specific Antibody.

J. Lee,^1,2 K. Lee,¹ J. Lee,¹ S. Song,¹ J. Lee,¹ S.-K. Kwon,¹ D. Joo,^1,2 K. Huh,^1,2 M. Kim,^1,2 S. Kim,^1,2 Y. Kim.^1,2
Outcomes of Sequential and En Bloc Transplants in the Elderly: 10 Year Review of UNOS Data.

V. Whittaker,¹ R. Gruessner,¹ A. Vikram,² A. Gruessner.
Outcomes of Small-for-Size Grafts in Adult Living Donor Liver Transplantation.

T. Klair,¹ E. Przybyszewski,¹ B. Samstein.²
Outcomes of Solid Organ Transplant Recipients with Pre-Existing Malignancies.

S. Acuna,^1,2,3 R. Sutradhar,^1,2 J. Kim,^1,2,4 N. Baxter.^1,2,3
Outcomes of Solid Organ Transplantation from an HIV Positive Donor to Negative Recipients.

S.-N. Lin,¹ M.-K. Tsai,¹ C.-Y. Luo,² C.-Y. Lee,¹ R.-H. Hu,¹ J.-M. Lee,¹ H.-S. Lai.¹
Outcomes of Solid Organ Transplants Following Simultaneous Solid Organ and Vascularized Composite Allograft Procurements.

M. Alhefzi,¹ M. Aycart,¹ G. Sharma,² N. Krezdorn,¹ E. Bueno,¹ S. Talbot,¹ M. Carty,¹ B. Pomahac,¹ S. Tullius.³
Outcomes of Super Obese Patients Undergoing Kidney Transplantation: A Propensity Match Analysis from the UNOS Dataset.

R. Gedaly, P. Kanthawar, X. Mei, M. Daily, M. Shah, J. Berger, A. Castellanos, F. Marti.
Outcomes of Transplant Recipients Treated with Cidofovir for Resistant or Refractory Cytomegalovirus Infection.

S. Mehta, M. Alfares, A. Valsamakis, S. Shoham, R. Boger, L. Lees, D. Ostrander, R. Avery.
Outcomes of Untreated Asymptomatic Bacteriuria in Renal Transplant Recipients: A Single-Center Experience.

W. Davis, R.-A. Lee, L. Daniels, S. Todd, K. True, P. Chong.
Outcomes with Steroids Alone for Biopsy-Proven Pancreas Transplant Rejection.

S. Salahuddin,¹ B. Astor,¹ S. Parajuli,¹ A. Djamali,¹ J. Odorico,² D. Mandelbrot.¹
Outcomes with the Use of Pediatric Donor Livers in Adult Recipients: Review of the UNOS Database.

K. Croome, D. Lee, J. Burns, J. Nguyen, D. Perry, C. Taner.

Jump to: View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z